446 related articles for article (PubMed ID: 21690428)
21. Nebulized Therapies in COPD: Past, Present, and the Future.
Barjaktarevic IZ; Milstone AP
Int J Chron Obstruct Pulmon Dis; 2020; 15():1665-1677. PubMed ID: 32764912
[TBL] [Abstract][Full Text] [Related]
22. Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease.
Cazzola M; Cavalli F; Usmani OS; Rogliani P
Expert Opin Drug Deliv; 2020 May; 17(5):635-646. PubMed ID: 32130023
[No Abstract] [Full Text] [Related]
23. Administration Technique and Acceptance of Inhaler Devices in Patients With Asthma or COPD.
Sadowski CA; Cor K; Cave A; Banh HL
Ann Pharmacother; 2015 Jun; 49(6):639-48. PubMed ID: 25814632
[TBL] [Abstract][Full Text] [Related]
24. How many instructions are required to correct inhalation errors in patients with asthma and chronic obstructive pulmonary disease?
Takaku Y; Kurashima K; Ohta C; Ishiguro T; Kagiyama N; Yanagisawa T; Takayanagi N
Respir Med; 2017 Feb; 123():110-115. PubMed ID: 28137486
[TBL] [Abstract][Full Text] [Related]
25. Pressurised metered-dose inhalers versus all other hand-held inhalers devices to deliver bronchodilators for chronic obstructive pulmonary disease.
Ram FS; Brocklebank DM; Muers M; Wright J; Jones PW
Cochrane Database Syst Rev; 2002; 2002(1):CD002170. PubMed ID: 11869627
[TBL] [Abstract][Full Text] [Related]
26. Inhalatory therapy training: a priority challenge for the physician.
Melani AS
Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
[TBL] [Abstract][Full Text] [Related]
27. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
Geller DE
Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
[TBL] [Abstract][Full Text] [Related]
28. Predictors of incorrect inhalation technique in patients with asthma or COPD: a study using a validated videotaped scoring method.
Rootmensen GN; van Keimpema AR; Jansen HM; de Haan RJ
J Aerosol Med Pulm Drug Deliv; 2010 Oct; 23(5):323-8. PubMed ID: 20804428
[TBL] [Abstract][Full Text] [Related]
29. Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD.
Svedsater H; Dale P; Garrill K; Walker R; Woepse MW
BMC Pulm Med; 2013 Dec; 13():72. PubMed ID: 24314123
[TBL] [Abstract][Full Text] [Related]
30. Device-handling study of a novel breath-actuated inhaler, Synchrobreathe®, versus a pMDI.
Balamurugan S; Apte K; Singh BP; Deb AK; Deshmukh C; Modi K; Godse A; Dhar R; Lahiri KR; Singh V; Pandya H; Rajan S; Vaidya A; Gaur V; Gogtay J
Respir Med; 2020 Jan; 161():105707. PubMed ID: 32056719
[TBL] [Abstract][Full Text] [Related]
31. Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes.
Levy ML; Carroll W; Izquierdo Alonso JL; Keller C; Lavorini F; Lehtimäki L
Adv Ther; 2019 Oct; 36(10):2547-2557. PubMed ID: 31478131
[TBL] [Abstract][Full Text] [Related]
32. Importance of inhaler devices in the management of airway disease.
Virchow JC; Crompton GK; Dal Negro R; Pedersen S; Magnan A; Seidenberg J; Barnes PJ
Respir Med; 2008 Jan; 102(1):10-9. PubMed ID: 17923402
[TBL] [Abstract][Full Text] [Related]
33. Switching treatments in COPD: implications for costs and treatment adherence.
Braido F; Lavorini F; Blasi F; Baiardini I; Canonica GW
Int J Chron Obstruct Pulmon Dis; 2015; 10():2601-8. PubMed ID: 26664108
[TBL] [Abstract][Full Text] [Related]
34. Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older.
Komase Y; Asako A; Kobayashi A; Sharma R
Int J Chron Obstruct Pulmon Dis; 2014; 9():1365-75. PubMed ID: 25525354
[TBL] [Abstract][Full Text] [Related]
35. Assessment of Inhaler Satisfaction and Determinants of High Satisfaction Among Korean COPD Patients.
Jang JG; Lee KH; Chung JH; Shin KC; Choi EY; Jin HJ; Ahn JH
J Korean Med Sci; 2022 Nov; 37(46):e327. PubMed ID: 36631025
[TBL] [Abstract][Full Text] [Related]
36. [The importance of selecting the right type of inhaler for patients with asthma and chronic obstructive pulmonary disease (COPD)].
Larsson K; Bjermer L; Svartengren M
Lakartidningen; 2019 Feb; 116():. PubMed ID: 30720857
[TBL] [Abstract][Full Text] [Related]
37. The Evolution of Pressurized Metered-Dose Inhalers from Early to Modern Devices.
Roche N; Dekhuijzen PN
J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):311-27. PubMed ID: 26824873
[TBL] [Abstract][Full Text] [Related]
38. Technical Evaluation of Soft Mist Inhaler Use in Patients with Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study.
Zhang W; Xu L; Gao S; Ding N; Shu P; Wang Z; Li Y
Int J Chron Obstruct Pulmon Dis; 2020; 15():1471-1479. PubMed ID: 32606655
[TBL] [Abstract][Full Text] [Related]
39. Cognitive impairment according to Montreal Cognitive Assessment independently predicts the ability of chronic obstructive pulmonary disease patients to maintain proper inhaler technique.
Iamthanaporn C; Wisitsartkul A; Chuaychoo B
BMC Pulm Med; 2023 Apr; 23(1):144. PubMed ID: 37101175
[TBL] [Abstract][Full Text] [Related]
40. Identifying the features of an easy-to-use and intuitive dry powder inhaler for asthma and chronic obstructive pulmonary disease therapy: results from a 28-day device handling study, and an airflow resistance study.
Virchow JC; Weuthen T; Harmer QJ; Jones S
Expert Opin Drug Deliv; 2014 Dec; 11(12):1849-57. PubMed ID: 25151851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
